Tuesday, January 10, 2023 7:45:20 AM
NVCR microwave device hype will not last and rapidly fading!!
Those who understand how it works know that its application is at best comparable to chemo in terms of effectiveness & the real life experiences of the prescribing doctors & their cancer patients has been increasingly confirming that!!
Why do you think with a bloated $10B market cap, its earnings are non-existence and dropping??
Comparatively speaking, Chemo kills the cancer as well as the normal cells..
And the helmet, based on it claim mode of action of interfering with replication of fast dividing cells, such as cancer cells, inhibit the division of those cells at the site where the microwaves are targeting. Obviously elsewhere in the body, the cancer cells lives happily and keep invading..
Now consider the fact that activated immune system effector cells, such as the T-cells, are also fast dividing. Meaning that the microwaves also inhibit division of the activated immune cells thus, inhibiting the division of the activated immune cells that might have been estimated in some ways. A defeated claim for immune cell activation!!
So the microwaves Inhibit not only cancer cells replication, but also, activated immune cell replication IMO..
And IMO, the lack of interest of the medical community based on the real life experience of their patients as well as their poor quality of their remaining life at massive cost to them are all supportive of that view!!
A new & innovative alternative that stimulate the totality of the naturally occurring immune system from within is urgently needed!!
Those who understand how it works know that its application is at best comparable to chemo in terms of effectiveness & the real life experiences of the prescribing doctors & their cancer patients has been increasingly confirming that!!
Why do you think with a bloated $10B market cap, its earnings are non-existence and dropping??
Comparatively speaking, Chemo kills the cancer as well as the normal cells..
And the helmet, based on it claim mode of action of interfering with replication of fast dividing cells, such as cancer cells, inhibit the division of those cells at the site where the microwaves are targeting. Obviously elsewhere in the body, the cancer cells lives happily and keep invading..
Now consider the fact that activated immune system effector cells, such as the T-cells, are also fast dividing. Meaning that the microwaves also inhibit division of the activated immune cells thus, inhibiting the division of the activated immune cells that might have been estimated in some ways. A defeated claim for immune cell activation!!
So the microwaves Inhibit not only cancer cells replication, but also, activated immune cell replication IMO..
And IMO, the lack of interest of the medical community based on the real life experience of their patients as well as their poor quality of their remaining life at massive cost to them are all supportive of that view!!
A new & innovative alternative that stimulate the totality of the naturally occurring immune system from within is urgently needed!!
Bullish
Recent NVCR News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/21/2026 08:00:26 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/08/2026 09:01:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 11:01:40 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 11:01:01 AM
- Novocure Reports First Quarter 2026 Financial Results • Business Wire • 04/30/2026 11:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/24/2026 08:08:39 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/20/2026 08:06:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/20/2026 08:05:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 09:04:13 PM
- Novocure to Report First Quarter 2026 Financial Results • Business Wire • 04/01/2026 11:00:00 AM
- Novocure shares gain on encouraging pancreatic cancer trial results • IH Market News • 03/26/2026 02:24:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 11:00:57 AM
- Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer • Business Wire • 03/26/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:33:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:32:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:32:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 09:06:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:54:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:53:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:42:44 PM
